If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.96    -0.002 (-0.21%)
Bid:
0.958
Ask:
0.962
Spread: 0.004 (0.418%)
Market Cap: $1.08b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Holding(s) in Company

12 Apr 2021 11:00

RNS Number : 1386V
BioPharma Credit PLC
12 April 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDGKMY29

Issuer Name

BIOPHARMA CREDIT PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Newton Investment Management Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Is the shareholder the same as the person subject to the notification obligation, above?

Yes

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

08-Apr-2021

6. Date on which Issuer notified

09-Apr-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

9.926571

0.000000

9.926571

136378417

Position of previous notification (if applicable)

10.02

N/A

10.02

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

CLASS/TYPE OF SHARES ISIN CODE(IF POSSIBLE)

NUMBER OF DIRECT VOTING RIGHTS (DTR5.1)

NUMBER OF INDIRECT VOTING RIGHTS (DTR5.2.1)

% OF DIRECT VOTING RIGHTS (DTR5.1)

% OF INDIRECT VOTING RIGHTS (DTR5.2.1)

GB00BDGKMY29

136378417

9.926571

Sub Total 8.A

136378417

9.926571%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

TYPE OF FINANCIAL INSTRUMENT

EXPIRATION DATE

EXERCISE/CONVERSION PERIOD

NUMBER OF VOTING RIGHTS THAT MAY BE ACQUIRED IF THE INSTRUMENT IS EXERCISED/CONVERTED

% OF VOTING RIGHTS

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

TYPE OF FINANCIAL INSTRUMENT

EXPIRATION DATE

EXERCISE/CONVERSION PERIOD

PHYSICAL OR CASH SETTLEMENT

NUMBER OF VOTING RIGHTS

% OF VOTING RIGHTS

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate Controlling Person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Is there proxy voting?

No

Name of the proxy holder

 

The number and % of voting rights held

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

09-Apr-2021

13. Place Of Completion

Uniondale, New York

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUUSKRAWUSARR
Date   Source Headline
20th Nov 20247:00 amRNSDirector Declaration
14th Nov 20245:39 pmRNSDirector Declaration
12th Nov 20247:00 amRNSSTATEMENT RE IMMUNOCORE HOLDINGS PLC
7th Nov 202412:15 pmRNSNEW INVESTMENT OF UP TO US$250 MILLION
4th Nov 202412:16 pmRNSDirector/PDMR Shareholding
1st Nov 202411:51 amRNSTotal Voting Rights
1st Nov 20247:00 amRNSUPDATE ON INVESTMENT
31st Oct 20247:00 amRNSNEW INVESTMENT OF US$35 MILLION
28th Oct 20246:15 pmRNSTransaction in Own Shares
25th Oct 20246:15 pmRNSTransaction in Own Shares
21st Oct 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Oct 20246:15 pmRNSTransaction in Own Shares
17th Oct 20246:15 pmRNSTransaction in Own Shares
11th Oct 20246:15 pmRNSTransaction in Own Shares
10th Oct 20246:15 pmRNSTransaction in Own Shares
9th Oct 20246:15 pmRNSTransaction in Own Shares
1st Oct 202411:00 amRNSTotal Voting Rights
30th Sep 20246:15 pmRNSTransaction in Own Shares
27th Sep 20246:15 pmRNSTransaction in Own Shares
27th Sep 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
26th Sep 20246:15 pmRNSTransaction in Own Shares
25th Sep 20246:15 pmRNSTransaction in Own Shares
24th Sep 20247:00 amRNSHalf-year Report
19th Sep 20247:00 amRNSDividend Declaration
5th Sep 20247:00 amRNSUPDATE RE COLLEGIUM PHARMACEUTICAL, INC.
2nd Sep 202410:56 amRNSTotal Voting Rights
30th Aug 20246:15 pmRNSTransaction in Own Shares
30th Aug 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
29th Aug 20246:15 pmRNSTransaction in Own Shares
28th Aug 20246:15 pmRNSTransaction in Own Shares
27th Aug 20246:15 pmRNSTransaction in Own Shares
23rd Aug 20246:15 pmRNSTransaction in Own Shares
22nd Aug 20246:15 pmRNSTransaction in Own Shares
21st Aug 20246:15 pmRNSTransaction in Own Shares
20th Aug 20246:15 pmRNSTransaction in Own Shares
19th Aug 20246:15 pmRNSTransaction in Own Shares
16th Aug 20246:15 pmRNSTransaction in Own Shares
16th Aug 202410:28 amRNSNotice of Half Year Results
15th Aug 20246:15 pmRNSTransaction in Own Shares
14th Aug 20246:15 pmRNSTransaction in Own Shares
13th Aug 20246:15 pmRNSTransaction in Own Shares
12th Aug 20246:15 pmRNSTransaction in Own Shares
9th Aug 20246:15 pmRNSTransaction in Own Shares
8th Aug 20246:15 pmRNSTransaction in Own Shares
7th Aug 20246:15 pmRNSTransaction in Own Shares
6th Aug 20246:15 pmRNSTransaction in Own Shares
5th Aug 20246:15 pmRNSTransaction in Own Shares
5th Aug 202411:28 amRNSDirector/PDMR Shareholding
2nd Aug 20246:15 pmRNSTransaction in Own Shares
1st Aug 20246:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.